Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on May 20, 2024 at 11:30 a.m. ET.
賓夕法尼亞州亞德利，2024 年 5 月 17 日（環球新聞專線）— Optinose 納斯達克股票代碼：OPTN）是一家專注於耳鼻喉科（ENT）和過敏專家治療的患者的製藥公司，今天宣佈，其管理團隊成員將在美國東部時間2024年5月20日上午11點30分在納斯達克舉行的H.C. Wainwright第二屆年度BioConnect投資者會議上介紹公司概況和業務最新情況。
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
要收聽演講的網絡直播，請訪問Optinose網站的投資者頁面。
A replay of the webcast will be available for 30 days following the conclusion of the event.
網絡直播的重播將在活動結束後的30天內提供。
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.
關於 Optinose
Optinose是一家專業製藥公司，致力於滿足耳鼻喉科（ENT）和過敏專家護理的患者的需求。要了解更多信息，請訪問 www.optinose.com 或者關注我們 X 和 領英。
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
Optinose 投資者聯繫方式
喬納森·尼利
jonathan.neely@optinose.com267.521.0531
Source: Optinose, Inc.
資料來源：Optinose, Inc.